Stress sensitivity and the development of affective disorders

被引:191
作者
Bale, Tracy L. [1 ]
机构
[1] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA
关键词
stress; affective disorder; CRF; sex differences; stress sensitivity;
D O I
10.1016/j.yhbeh.2006.06.033
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Depressive disorders are the most common form of mental illness in America, affecting females twice as often as males. The great variability of symptoms and responses to therapeutic treatment emphasize the complex underlying neurobiology of disease onset and progression. Evidence from human and animal studies reveals a vital link between individual stress sensitivity and the predisposition toward mood disorders. While the stress response is essential for maintenance of homeostasis and survival, chronic stress and maladaptive responses to stress insults can lead to depression or other affective disorders. A key factor in the mediation of stress responsivity is the neuropeptide corticotropin-releasing factor (CRF). Studies in animal models of heightened stress sensitivity have illustrated the involvement of CRF downstream neurotransmitter targets, including serotonin and norepinephrine, in the profound neurocircuitry failure that may underlie maladaptive coping strategies. Stress sensitivity may also be a risk factor in affective disorder development susceptibility. As females show an increased stress response and recovery time compared to males, they may be at an increased vulnerability for disease. Therefore, examination of sex differences in CRF and downstream targets may aid in the elucidation of the underlying causes of the increased disease presentation in females. While we continue to make progress in our understanding of mood disorder etiology, we still have miles to go before we sleep. As an encouraging number of new animal models of altered stress sensitivity and negative stress coping strategies have been developed, the future looks extremely promising for the possibility of a new generation of drug targets to be developed. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:529 / 533
页数:5
相关论文
共 62 条
[1]   AMYGDALA KINDLING, ANXIETY, AND CORTICOTROPIN-RELEASING FACTOR (CRF) [J].
ADAMEC, RE ;
MCKAY, D .
PHYSIOLOGY & BEHAVIOR, 1993, 54 (03) :423-431
[2]   Stress effects on limbic function and behavior [J].
Adamec, RE .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (08) :1173-1175
[3]  
ALTEMUS M, 1994, ANXIETY, V1, P251
[4]   ELEVATED CSF CRF IN SUICIDE VICTIMS [J].
ARATO, M ;
BANKI, CM ;
BISSETTE, G ;
NEMEROFF, CB .
BIOLOGICAL PSYCHIATRY, 1989, 25 (03) :355-359
[5]  
Arborelius L, 2000, J PHARMACOL EXP THER, V294, P588
[6]   The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[7]   CRF and CRF receptors: Role in stress responsivity and other behaviors [J].
Bale, TL ;
Vale, WW .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :525-557
[8]  
Bale TL, 2003, J NEUROSCI, V23, P5295
[9]   Identification of depression by medical and surgical general hospital physicians [J].
Balestrieri, M ;
Bisoffi, G ;
Tansella, M ;
Martucci, M ;
Goldberg, DP .
GENERAL HOSPITAL PSYCHIATRY, 2002, 24 (01) :4-11
[10]  
BANKI CM, 1987, AM J PSYCHIAT, V144, P873